Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Human antibodies to PCSK9 for use in methods of treating particular groups of subjects

Human antibodies to PCSK9 for use in methods of treating particular groups of subjects

US Patent 12083176 · Granted Sep 10, 2024

Estimated economic value: $97,825,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treating patients with heterozygous familial hypercholesterolemia (h2022
Methods for treating patients with heterozygous familial hypercholesterolemia (h2022
Methods for treating patients with heterozygous familial hypercholesterolemia (h2022
Human antibodies to PCSK9 for use in methods of treating particular groups of su2022
Human antibodies to PCSK9 for use in methods of treating particular groups of su2022
Human antibodies to PCSK9 for use in methods of treating particular groups of su2022
Malic enzyme inhibitors2022
Methods for treating patients with heterozygous familial hypercholesterolemia (h2020
Methods for treating patients with heterozygous familial hypercholesterolemia (h2020
Methods for treating patients with heterozygous familial hypercholesterolemia (h2020
Dosing regimens for use with PCSK9 inhibitors2019
Dosing regimens for use with PCSK9 inhibitors2019